Pay in 4 interest-free payments of $5.80 Learn more
Ships within 48 hours · Estimated delivery Sep 4 - Sep 9
Studied on the strength of the ghrelin-mimetic mechanism, but not established as an approved therapy
Regional Insights North America GLP-1 Receptor Agonist Market Trends North America dominates the GLP-1 receptor agonist market with a 41.8% share in 2025 , driven by the high prevalence of diabetes and obesity, coupled with strong healthcare infrastructure and widespread insurance coverage
Follow US
Indeed, let-7, a well-known tumor suppressor that regulates the multiple components of IGF-1 signaling pathway ( Table 1 ), is currently targeted as a potential miRNA replacement treatment for cancer
von Eckardstein et al, 1994)
US$ 21.77
US$ 22.32
US$ 22.14
